Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARV-ACT Phase I Step 1 pharmacokinetic interaction study in Malawi
PACTR2010030001871293Phase 1Completed
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- Aug 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of artemether, lumefantrine, amodiaquine, artesunate, dihydroartemisinin and 9 more in malaria and human immunodeficiency virus infection (HIV) (11 arms), sponsored by Liverpool School of Tropical Medicine. Primary endpoint: Pharmacokinetic interaction assessment. Started Aug 2010; status: completed.
02
Drugs
artemetherlumefantrineamodiaquineartesunatedihydroartemisinin
03
Conditions
malariahuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR2010030001871293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR2010030001871293.